Elsevier

International Journal of Cardiology

Volume 199, 15 November 2015, Pages 106-115
International Journal of Cardiology

Risk of all-cause mortality and cardiovascular disease associated with secondhand smoke exposure: A systematic review and meta-analysis

https://doi.org/10.1016/j.ijcard.2015.07.011Get rights and content

Abstract

Background

Emerging studies have assessed the association between secondhand smoke (SHS) exposure and cardiovascular disease (CVD) as well as all-cause mortality. However, findings were not consistent due to the heterogeneity of study characteristics.

Methods

PubMed and Embase were searched through May 2014 for prospective cohort and case–control studies investigating the associations of SHS exposure in never smokers with all-cause mortality and the risk of CVD. The main analysis was performed in studies using self-reported SHS exposure and secondary analysis was performed in studies using objectively measured SHS exposure. Summary estimates were calculated using random-effects models.

Results

Twenty-three prospective and 17 case–control studies were included. The pooled relative risks (RR) for never smokers exposed to SHS in comparison with those unexposed were 1.18 [95% confidence interval (CI): 1.10–1.27] for all-cause mortality (12 studies), and 1.23 (1.16–1.31) for CVD (38 studies). The association of SHS exposure with CVD was markedly stronger among studies conducted in China (RR = 1.65, 95% CI 1.27–2.13) than that in the US (RR = 1.09, 95% CI 1.03–1.16). Studies using objectively measured SHS exposure demonstrated a slightly higher risk for CVD compared with those using self-reported SHS exposure.

Conclusions

Exposure to SHS significantly increased the risk for all-cause mortality and CVD. The risk associated with SHS exposure was large in China while the risk was only modest in the US. Studies using objectively measured SHS exposure may yield a higher risk of CVD than those using self-reported SHS exposure.

Introduction

Cardiovascular disease (CVD) remains the leading cause of death worldwide [1]. Among various modifiable risk factors of CVD, smoking is one of the most significant. Secondhand smoke (SHS), also known as passive smoking, was associated with 25% to 30% increased risk of coronary heart disease (CHD), as suggested by previous systematic reviews and meta-analyses [2], [3], [4], [5]. With over 30% of the world's non-smokers exposed to SHS [6], the worldwide burden of deaths from CVD attributable to SHS is immense.

A number of new studies assessing the association between SHS and CVD have been published following the last comprehensive meta-analysis in 1999 [2]. Most of these studies demonstrated an increased risk of CVD associated with SHS, while others found little or no relationship, presumably due to the heterogeneity of study characteristics (e.g. gender distribution, ethnicity, or source of exposure). For example, Gallo et al. reported a significantly increased risk of CVD mortality related to SHS exposure at home but not to exposure at workplaces [7]. In a large prospective study in Norway, Iversen et al. found that the risk of myocardial infarction was increased in passive smoking women but not in passive smoking men [8]. Additionally, by analyzing data from the American Cancer Society's Cancer Prevention Study I, Enstrom et al. failed to detect a significant association of exposure to SHS with CHD mortality [9], while in a cohort study in China, He et al. showed that never smokers exposed to SHS had a 2-fold risk of CHD death [10]. Therefore, the question as to what extent SHS is associated with CVD risk and whether the association varied by important study characteristics warrants an in-depth reassessment of the relationship between SHS exposure and CVD.

Early studies investigating the relationship between SHS and CVD mainly relied on participants' self-reported SHS exposure at home or workplaces. However, this questionnaire-based assessment of SHS might be subject to misclassification. In 2004, for the first time, Whincup et al. evaluated the risk of CHD associated with SHS using an objective assessment of SHS exposure by measuring concentrations of serum cotinine, showing that the risk of CHD might be increased by 54% to 89% in never smokers with different levels of SHS exposure [11]. Since the objective measurement was able to capture the total SHS exposure from all sources, researchers argued that the cardiovascular impact of SHS exposure may be as large as that of active smoking and that previous assessment of SHS by self-reported exposure could have underestimated the impact of SHS [3]. Following Whincup, three studies were conducted using this objective cotinine-based measurement to examine the risk of CVD related with SHS. Available evidence needs to be synthesized to generate a more precise risk estimate of CVD associated with objectively assessed SHS exposure and to determine whether self-reported measurement of SHS did bias the risk of CVD downward.

SHS exposure was not only related to risk of cardiovascular morbidity and mortality, but also increased the risk of other causes of death, such as death due to breast cancer, lung cancer, or chronic obstructive pulmonary disease [12], [13], [14], [15]. Literatures have suggested an association between SHS and all-cause mortality. However, the magnitude of the association has not been systematically assessed.

Therefore, we conducted the current meta-analysis to 1) estimate the relative risk (RR) of CVD associated with self-reported SHS exposure as well as objectively measured SHS exposure, and find out whether the association varied by important study characteristics, and 2) estimate the RR of all-cause mortality associated with SHS exposure.

Section snippets

Search strategy

We performed this meta-analysis following the proposed MOOSE (Meta-Analysis of Observational Studies in Epidemiology) statement.

Two qualified investigators (X.L. and J.S.) conducted database search and discrepancies were resolved by discussion and consensus with a senior investigator (Y.X.). We searched PubMed and Embase for prospective cohort and case–control studies published from inception date to May 2014, which investigated the association between SHS exposure and the risk of all-cause

Identification of studies

Our initial electronic database search yielded 752 publications: 521 from PubMed and 231 from Embase. After screening titles and abstracts, we identified 58 articles for further full-text review. Among those, we identified two studies which met our inclusion criteria but the required data were not reported [19], [20]. However, contact with the authors was not successful because the two studies were conducted three decades ago. Additional 4 articles were obtained from reference lists of

Discussion

This meta-analysis is the most comprehensive study that evaluated the effect of SHS exposure on all-cause mortality and CVD. The number of studies included in our analysis was almost doubled compared with that of previous ones [2], [3], [4]. Our analysis indicated that never smokers exposed to SHS, compared with those unexposed, had a significantly increased risk of 18% for all-cause mortality, 23% for CVD, 23% for CHD, and 29% for stroke. Various study characteristics, such as gender and age

Conclusion

Our study provides sufficient evidence that exposure to SHS significantly increased the risk for all-cause mortality and CVD. In addition, the risk associated with SHS exposure was large in China while the risk was only modest in the US. Studies using objectively measured SHS exposure may yield a higher risk of CVD than those using self-reported SHS exposure.

The following are the supplementary data related to this article.

. Funnel plot for studies of the association between SHS and all-cause

Funding

This work is supported by the National Natural Science Foundation of China (81100564), the Shanghai Shen-Kang Hospital Development Center Foundation (shdc12012301), and the Chinese Society of Endocrinology Foundation (12020250315).

Conflicts of interest

No potential conflicts of interest relevant to this article were reported.

Author contributions

XL, JS, and YX proposed the study protocol. YB contributed to the interpretation of data and edited the manuscript. XL and JS performed database searching, data extraction, statistical analyses, and wrote the first manuscript. MX, JL, and LZ provided critical suggestions. YX reviewed and edited the manuscript. All authors approved the final version.

References (63)

  • M. Ciruzzi et al.

    Case–control study of passive smoking at home and risk of acute myocardial infarction. Argentine FRICAS Investigators. Factores de Riesgo Coronario en America del Sur

    J. Am. Coll. Cardiol.

    (1998)
  • D.G. Meyers et al.

    Cardiovascular effect of bans on smoking in public places: a systematic review and meta-analysis

    J. Am. Coll. Cardiol.

    (2009)
  • R. Qin et al.

    Excess risk of mortality and cardiovascular events associated with smoking among patients with diabetes: meta-analysis of observational prospective studies

    Int. J. Cardiol.

    (2013)
  • M.E. LeVois et al.

    Publication bias in the environmental tobacco smoke/coronary heart disease epidemiologic literature

    Regul. Toxicol. Pharmacol.

    (1995)
  • A. Alwan

    Global Status Report on Noncommunicable Diseases 2010

    (2011)
  • J. He et al.

    Passive smoking and the risk of coronary heart disease—a meta-analysis of epidemiologic studies

    N. Engl. J. Med.

    (1999)
  • J. Barnoya et al.

    Cardiovascular effects of secondhand smoke: nearly as large as smoking

    Circulation

    (2005)
  • M. Thun et al.

    Epidemiologic studies of fatal and nonfatal cardiovascular disease and ETS exposure from spousal smoking

    Environ. Health Perspect.

    (1999)
  • M.R. Law et al.

    Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence

    BMJ

    (1997)
  • V. Gallo et al.

    Second-hand smoke, cotinine levels, and risk of circulatory mortality in a large cohort study of never-smokers

    Epidemiology

    (2010)
  • B. Iversen et al.

    Active and passive smoking and the risk of myocardial infarction in 24,968 men and women during 11 year of follow-up: the Tromso Study

    Eur. J. Epidemiol.

    (2013)
  • J.E. Enstrom et al.

    Environmental tobacco smoke and tobacco related mortality in a prospective study of Californians, 1960–98

    BMJ

    (2003)
  • P.H. Whincup et al.

    Passive smoking and risk of coronary heart disease and stroke: prospective study with cotinine measurement

    BMJ

    (2004)
  • K. Pirie et al.

    Passive smoking and breast cancer in never smokers: prospective study and meta-analysis

    Int. J. Epidemiol.

    (2008)
  • R. Taylor et al.

    Meta-analysis of studies of passive smoking and lung cancer: effects of study type and continent

    Int. J. Epidemiol.

    (2007)
  • P. Vineis et al.

    Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study

    BMJ

    (2005)
  • US Department of Health and Human Services

    The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General

    (2006)
  • S.D. Walter et al.

    A comparison of several point estimators of the odds ratio in a single 2 × 2 contingency table

    Biometrics

    (1991)
  • S. Duval et al.

    Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis

    Biometrics

    (2000)
  • J.P. Vandenbroucke et al.

    Active and passive smoking in married couples: results of 25 year follow up

    Br. Med. J.

    (1984)
  • C. Garland et al.

    Effects of passive smoking on ischemic heart disease mortality of nonsmokers. A prospective study

    Am. J. Epidemiol.

    (1985)
  • Cited by (52)

    • Association of exposure to environmental tobacco smoke at home and risk of mortality among US never smokers by race/ethnicity, education, and income

      2022, Preventive Medicine
      Citation Excerpt :

      Homa et al., 2015; Tsai et al., 2018; Shastri et al., 2020) Pooled evidence from cohort and case-control studies has shown a significantly positive association between ETS exposure and the risk of all-cause mortality (RR = 1.18, 95%CI: 1.10–1.27) among never smokers.( Lv et al., 2015) However, despite known differences in exposure to ETS as well as substantial disparities in mortality rates by race/ethnicity and socioeconomic status in the US population,(Chetty et al., 2016; Shiels et al., 2017) there is little prior data evaluating associations between ETS and mortality by race/ethnicity, education, or household income. Furthermore, most prior studies were conducted in cohorts of volunteers(Garland et al., 1985; Svendsen et al., 1987; Helsing et al., 1988; Sandler et al., 1989; Humble et al., 1990) that do not reflect either the racial/ethnic or the socioeconomic diversity of the US population.

    • Secondhand smoke and the risk of incident cardiovascular disease among never-smoking women

      2022, Preventive Medicine
      Citation Excerpt :

      Previous meta-analyses reported case-control and cohort studies on the positive associations of SHS with risks of IHD, stroke, and CVD incidence and mortality (He et al., 1999; Fischer and Kraemer, 2015; Lv et al., 2015; Khoramdad et al., 2020). However, prospective cohort studies on the association between SHS and risk of incident CVD were conducted in the US, UK, and Norway, but not in Asian countries (Lv et al., 2015). Thus, this study aimed to examine the association between SHS and the risk of incident IHD and stroke among women by using a large cohort of Japanese populations.

    • Cardiovascular Disorders

      2022, Comprehensive Clinical Psychology, Second Edition
    View all citing articles on Scopus
    1

    X.L. and J.S. contributed equally to this work. All authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation.

    View full text